Camp4 Therapeutics (CAMP) Operating Expenses (2023 - 2026)

Camp4 Therapeutics has disclosed Operating Expenses across 4 years of filings, most recently posting $14.4 million for Q1 2026.

• Operating Expenses for Q1 2026 came in at $14.4 million, up 2.92% year-over-year; the trailing twelve-month figure through Mar 2026 was $56.5 million (up 2.99% YoY), and the FY2025 annual result was $56.1 million, up 4.3% from the prior year.
• Operating Expenses came in at $14.4 million for Q1 2026 at Camp4 Therapeutics, up from $13.1 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $14.7 million in Q4 2024 to a low of $12.7 million in Q2 2024.
• The 4-year median for Operating Expenses is $13.5 million (2024), against an average of $13.7 million.
• Peak annual rise in Operating Expenses reached 14.71% in 2025, while the deepest fall reached 10.64% in 2025.
• Camp4 Therapeutics' Operating Expenses stood at $13.5 million in 2023, then gained by 8.98% to $14.7 million in 2024, then fell by 10.64% to $13.1 million in 2025, then advanced by 9.46% to $14.4 million in 2026.
• The last three Operating Expenses figures came in at $14.4 million (Q1 2026), $13.1 million (Q4 2025), and $14.4 million (Q3 2025), per Business Quant data.